Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Ejhaem|July 9, 2026
Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsVelizar Shivarov, Gergana Tsvetkova, Evgueniy Hadjiev, et al.Human Immunology|January 27, 2023
The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasmsVelizar Shivarov, Gergana Tsvetkova, Evgueniy Hadjiev, et al.Experimental Hematology|October 5, 2020
Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesisMilena Ivanova, Gergana Tsvetkova, Tsvetelin Lukanov, et al.HLA|April 1, 2023
Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F-positive myeloproliferative neoplasmsMilena Ivanova, Gergana Tsvetkova, Spaska Lessichkova, et al.Cancers|July 15, 2026
Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative NeoplasmsVelizar Shivarov, Gergana Tsvetkova, Ilina Micheva, et al.Cell Biology International|April 9, 2008
Characterization of mesenchymal stem cells isolated from the human umbilical cordSnejana Kestendjieva, Dobroslav Kyurkchiev, Gergana Tsvetkova, et al.Frontiers in Immunology|October 1, 2024
Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasmsVelizar Shivarov, Gergana Tsvetkova, Ilina Micheva, et al.Central-European Journal of Immunology|May 20, 2020
Biclonal myeloma in renal failureMilena K Nikolova-Vlahova, Miroslava Kamburova, Julieta Hristova, et al.Pageof 1